Dusa

Visual Financials
Company Name: DUSA Pharmaceuticals Inc.
Ticker Symbol: DUSA
CIK Number: 0000879993
WWW Address: www.dusapharm.com
CEO: Robert Doman
No. of Employees: 99
Common Issue Type: CS
Business Description:DUSA Pharmaceuticals, Inc. is a vertically integrated dermatology company that is developing and marketing Levulan photodynamic therapy ('PDT') and other products for common skin conditions.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 23.77 Down -0.08 23.81 23.86 23.77 22.58 22.44 50
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 0.0 0.0 0.00  0.00 0.0 0.0 26.54 - 18.76
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close22.56$
PE Ratio - LTM0.0
Market Capitalisation0.0mil
Latest Shares Outstanding0.0mil
Earnings pS (EPS)$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee471,834$
Effective Tax Rate0.0%
Float0.0mil
Float as % of Shares Outstanding%
Foreign Sales2mil
Domestic Sales43mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.00$
Cash pS0.00$
Book-Value pS$
Tangible Book-Value pS0.00$
Cash Flow pS$
Free Cash Flow pS$
KEY FIGURES (LTM): Price info
Price/Book Ratio
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group234.0%
P/E as % of Sector Segment166.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---2.014,24584,609
4 Weeks23.5421.8423.49-3.910,650202,359
13 Weeks24.4821.8422.092.111,534726,671
26 Weeks24.4818.7621.743.834,0914,227,380
52 Weeks26.5418.7624.60-8.325,5866,396,509
YTD24.4819.67-11.316,7071,804,421
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
22.2922.4323.2822.3523.000.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.0
Income0.0
Dividend0.0
Capital SpendingNA
R&D0.11NA10.98
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %15.23.121.0
Earnings %-89.4-100.0170.8
EPS %-86.7-100.0154.5
EPS $-0.13-0.190.17
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio78.17
Current Ratio5.6
Quick Ratio (Acid Test)4.9
Liquidity Ratio (Cash)4.36
Receivables Turnover12.9
Average Collection Period28
Working Capital/Equity105.1
Working Capital pS1.21
Cash-Flow pS0.32
Free Cash-Flow pS0.31
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.98
Financial Leverage Ratio (Assets/Equity)1.3
Debt Ratio25.6
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested11.6
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-2.25
Enterprise Value (EV)/Free Cash Flow2.25
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM56.9
P/E Ratio (26 weeks ago) - LTM18.1
P/E Ratio (52 weeks ago) - LTM17.2
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group234.0
P/E as % of Sector Segment166.0
Current 12 Month Normalized P/E Ratio - LTM66.7
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS0.26
Tangible Book Value pS - LTM0.00
Book Value pS - LTM
Capital Invested pS0.00
Cash pS - LTM0.00
Cash Flow pS - LTM
Free Cash Flow pS - LTM
Earnings pS (EPS)
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin16.72
Free Cash Flow Margin 5YEAR AVG-2.44
Net Profit Margin16.2
Net Profit Margin - 5YEAR AVRG.
Equity Productivity1.60
Return on Equity (ROE)25.9
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity1.60
Return on Capital Invested (ROCI)25.9
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity1.40
Return on Assets (ROA)19.3
Return on Assets (ROA) - 5YEAR AVRG.
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin15.0
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle169
Revenue per Employee471,834
Net Income per Employee76,246
Average Collection Period30
Receivables Turnover12.9
Day's Inventory Turnover Ratio139
Inventory Turnover2.6
Inventory/Sales6.2
Accounts Payble/Sales1.77
Assets/Revenue0.71
Net Working Capital Turnover1.52
Fixed Assets Turnover24.69
Total Assets Turnover1.4
Revenue per $ Cash1.85
Revenue per $ Plant28.29
Revenue per $ Common Equity1.60
Revenue per $ Capital Invested1.60
Selling, General & Adm/tive (SG&A) as % of Revenue55.9
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue11.6
R&D Expense as % of Revenue - 5YEAR AVRG.11.6

  


Your Recent History
NASDAQ
DUSA
Dusa
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.